Factors influencing the utilization of research findings by health policy-makers in a developing country: the selection of Mali's essential medicines by Albert, Michael A et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
Health Research Policy and Systems
Open Access Research
Factors influencing the utilization of research findings by health 
policy-makers in a developing country: the selection of Mali's 
essential medicines
Michael A Albert*1, Atle Fretheim2 and Diadié Maïga3
Address: 1Department of General Practice and Community Medicine, University of Oslo, P.O. Box 1130, Blindern, N-0318, Oslo, Norway, 
2Norwegian Knowledge Centre for the Health Services, P.O. Box 7004, St. Olavs Plass, N-0130, Oslo, Norway and 3Direction of Pharmaceuticals 
and Medicines, Ministry of Health, B.P. E-782, Bamako, Mali
Email: Michael A Albert* - michael.a.albert@gmail.com; Atle Fretheim - atle.fretheim@nokc.no; Diadié Maïga - diadie_sarmoye@yahoo.fr
* Corresponding author    
Abstract
Background: Research findings are increasingly being recognized as an important input in the
formation of health policy. There is concern that research findings are not being utilized by health
policy-makers to the extent that they could be. The factors influencing the utilization of various
types of research by health policy-makers are beginning to emerge in the literature, however there
is still little known about these factors in developing countries. The object of this study was to
explore these factors by examining the policy-making process for a pharmaceutical policy common
in developing countries; an essential medicines list.
Methods: A study of the selection and updating of Mali's national essential medicines list was
undertaken using qualitative methods. In-depth semi-structured interviews and a natural group
discussion were held with national policy-makers, most specifically members of the national
commission that selects and updates the country's list. The resulting text was analyzed using a
phenomenological approach. A document analysis was also performed.
Results: Several factors emerged from the textual data that appear to be influencing the utilization
of health research findings for these policy-makers. These factors include: access to information,
relevance of the research, use of research perceived as a time consuming process, trust in the
research, authority of those who presented their view, competency in research methods, priority
of research in the policy process, and accountability.
Conclusion: Improving the transfer of research to policy will require effort on the part of
researchers, policy-makers, and third parties. This will include: collaboration between researchers
and policy-makers, increased production and dissemination of relevant and useful research, and
continued and improved technical support from networks and multi-national organizations. Policy-
makers from developing countries will then be better equipped to make informed decisions
concerning their health policy issues.
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Background
Most health researchers and those who fund health
research would like to believe that the work they produce
and support is influencing practice and policy and conse-
quently leading to actual improvements in health care
delivery. The study of research's influence on policy has
had a long and rich background, from early work on the
utilization of social science knowledge in government and
public policy [1,2], to more recent inquiries into the utili-
zation of systematic reviews by policy-makers [3]. While
the various models of policy-processes that have emerged
in this field demonstrate that there are many ways in
which research may be influencing policy [4,5], it is
widely recognized that the level of research utilization by
policy-makers is lower than it could be [6]. The body of
literature examining the factors influencing the utilization
of research findings by policy-makers is increasing. From
the two systematic reviews on the subject, common fac-
tors are emerging such as: interactions and personal con-
tact between researchers and policy-makers, timeliness
and relevance of the research findings, the inclusion of
summaries with clear recommendations, mistrust
between researchers and policy-makers, and power and
budget struggles [3,7]. Most of these findings are however
based on studies from industrialized countries, and thus
more research is needed into the factors that affect the
linkage between research and policy in developing coun-
tries. With their limited resources these countries have
much to gain from well-informed health policies [8].
The present research focused on one specific health pol-
icy: Mali's national essential medicines list (EML). In
1975 the World Health Organization (WHO) introduced
the global concept of essential medicines with the first
model EML introduced two years later. Updates every two
years have lead to the current 14th model list [9]. This ref-
erence document is usually used as a starting point for a
national list, however each country requires additional
information from monitoring and research for its specific
health situation [10]. Like many developing countries, the
West African country of Mali has a national EML. The Mal-
ian list does contain several medicines not present on the
WHO model list, including an extra section for "improved
traditional medicines." The country's official criteria for
the selection of medicines for the list at the time of this
study included: harmlessness, efficacy, relevance to the
disease pattern, availability on the international market,
and cost-effectiveness [11]. Since research findings have
much to contribute to these criteria, the factors influenc-
ing their utilization, as perceived by policy-makers, were
examined.
Methods
A qualitative approach was used for the present research.
By focusing on a specific health policy, participants had
the opportunity to concretely discuss their experiences in
the policy-making process, including both group and
individual experiences. After presenting the protocol to
the National Institute of Public Health Research in Mali,
the principle investigator was informed that written
approval from the ethical committee was not necessary.
Participants
A purposive sampling technique was used by selecting key
informants from the national commission that selects and
updates Mali's national EML. The commission is com-
posed of various Ministry of Health staff including health
program managers, technical advisors, pharmacists, local
medical practitioners considered experts in their field, and
technical advisors from the WHO and the European
Union. At least one individual from each of these groups
was purposively included in the study. One health man-
ager who was not on the commission was mentioned in
initial interviews as having played a significant role in the
policy-making process, and was recommended for partic-
ipation. This person was also included in the study. One
member of the commission who was available chose not
to participate since the interviewer did not have a signed
letter from the Ministry of Health. A total of nineteen pol-
icy-makers (17 men and 2 women) took part. While there
were 33 members on the commission, data saturation had
been reached as consecutive interviews yielded diminish-
ing returns of new information and so further interview-
ing was deemed unnecessary [12].
Data collection
The principle investigator (MA) conducted 19 in-depth,
semi-structured interviews in French (33–89 minutes),
between September and December 2005. The interview
guide (see Additional file 1: Interview guide) was largely
based on the draft interview schedule for assessing
research utilization in policy-making provided by Hanney
and colleagues as an additional file in their review of
research utilization [6]. The topics discussed included: key
informants and policy-makers in the policy-process, per-
ceived importance of research findings in the policy-mak-
ing process, forms of communication found to be useful,
different ways research can be used, how well equipped
the commission was in absorbing research findings, spe-
cific aspects of research that made it useful, presentation/
format of research findings, the inclusion of traditional
medicines on the list, barriers and facilitators to research
utilization, and policy-makers' recommendations of how
to increase their utilization of research findings. Partici-
pants were asked about specific decisions that may have
been difficult to make, including discrepancies between
the WHO and Malian EMLs. When "personal expertise"
was mentioned as a main source of information in the
policy-making process, the acquisition of this expertiseHealth Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
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through possible utilization of research findings within
the individual's career was also discussed.
A natural group discussion, defined as a group interview
with "people who know each other already" [12] was also
conducted (55 minutes). All 19 interviewees were invited
knowing that many would not attend. Four individuals
participated in the group discussion. MA gave a short pres-
entation of the research and discussed the preliminary
findings. Participants were asked to comment and a group
discussion of key topics followed, with MA and DM facil-
itating.
A document analysis was also performed with the main
purpose of validating the information received during
interviews and the group discussion. Documents were
obtained from the secretary for the commission and the
individual who had prepared the technical notes for the
commission. The documents covered several updates of
the EML that have taken place over the last 10 years. They
included the technical notes used by the commission, the
documents used to prepare these notes, minutes from
meetings, a critical analysis of the country's EML, a synthe-
sis of the decisions made, copies of emails sent to and
received from contacts abroad, and Internet printouts.
All but four of the interviews and the natural group discus-
sion were recorded and transcribed by MA, who also took
in-depth notes throughout each session. For those that
were not recorded – at the requests of the interviewees –
MA went over the in-depth notes and produced a detailed
summary the same day as the session.
Analysis
All interviews were analyzed based on Giorgi's phenome-
nological approach [13]. The analysis followed the fol-
lowing steps: (i) going over all the textual data to gain an
overall impression, by MA; (ii) identifying all comments
that appeared significant to the research, extracting these
meaning units and translating them into English, by MA;
(iii) independent abstracting of the meaning units by MA
and AF, followed by discussion and consensus; (iv) inde-
pendent categorization and summarization of abstrac-
tions into factors influencing the utilization of research
findings as perceived by policy-makers, by MA and AF, fol-
lowed by discussion and consensus; and finally (v) return-
ing to the extracted text to ensure a good fit with the final
factors, by MA. The analysis of the group discussion fol-
lowed a similar process, however AF only participated in
step (v). The document analysis was used to validate state-
ments made in the interviews. Documents were also ana-
lyzed to determine the source of the information provided
to the commission and to determine the extent to which
the information included research findings. Throughout
the analysis process preconceptions were shared and criti-
cally reflected on between the investigators.
Results
The factors that emerged from the interviews and group
discussion are presented here. The embedded quotations
were translated from French by MA and are included here
for illustrative purposes.
Access to information
"The big ticket, at least in the case of Mali, and certainly the
case for most African countries where we have problems with
quality human resources and regular access to scientific infor-
mation is the means to allow these people to keep themselves
permanently informed," (participant 13, male).
Access to information was discussed in great depth, often
accompanied by the statement "we do not have the
means". While the Internet and various online resources
were mentioned as useful in improving access to research,
many of the policy-makers are still not connected and
those who are have limited, if any, access to paid sites.
Even at the local level it was perceived that the transfer of
information from research institutions to policy-makers is
poor.
Limited capacity in accessing research findings was also
stated as hindering its use. If a policy-maker has extra staff
or is a supervisor of students who can search, gather, and
compile the information, research findings are more
likely to get used. The availability of key texts that supply
such information was also seen as facilitating the utiliza-
tion of research findings. In addition, the more contacts
available to policy-makers – be they local experts or inter-
national organizations abroad – the greater access policy-
makers felt they had to research findings.
Language was discussed as well. Mali's official language is
French and while policy-makers agreed that "the scientific
language is very readable," (participant 11, female), and
could largely be understood even without a solid grasp of
English, many also stated that this was a problem. "It is a
serious handicap, serious," (participant 2, male). Policy-mak-
ers depend greatly on information available to them in
French, and this was felt to be limiting. "If I understood
English... I am sure that I could do so much more for everyone,"
(participant 8, male). Additionally, it was apparent from
the document analysis that almost all documents used by
the commission came from French sources.
Relevance of research findings
It was stated in the group discussion that most research
that is produced is irrelevant to policy-making. Research-
ers were described as "doing activities to survive," (partici-
pant 7, male), and not necessarily to answer questions thatHealth Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
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need answering. "That which is pertinent is not funded,"
(participant 9, male). It was proposed that collaboration
between researchers and policy-makers could allow pol-
icy-makers to give some input into the research process.
Time consuming process
When discussing the presentation of research findings,
interviewees indicated that a lengthy report or publication
would not be read, and recommended that researchers
provide short and concise documents. In fact, policy-mak-
ers stated that research utilization is already a lengthy and
time-consuming process. "Usually I do not have the time,"
(participant 18, male). Even if research is considered
important, it still requires a significant amount of time to
search, locate, access and review the relevant literature. "It
demands sacrifice" (participant 11, female).
Trust in the research
Policy-makers want information they can trust. Those
who were able to commission research found this to be
important in allowing them to utilize the findings. This
was not only because it improved the relevance of the
research, but also because it increased the extent to which
policy-makers trusted the research. As one policy-maker
metaphorically stated: "If I told you, behind that door there
is a cup of tea with sugar and then I give you a cup of tea with
sugar here. Which tea can you appreciate? What is outside is
not bad, but what is in my hand, that, I can defend," (partici-
pant 8, male).
While no particular form of presentation was stated as
being more useful than another, policy-makers indicated
that reports should be short (discussed above), and that
they would like sections dedicated to methodologies and
references. These are considered necessary for determining
the quality of the research and therefore whether or not it
can be trusted. Policy-makers indicated that their confi-
dence in journals that publish research findings is also rel-
evant. "If it's in the Lancet or the New England Journal of
Medicine, or Science, well, right away we jump on it," (partic-
ipant 16, male). Similarly, research that is supplied by a
trusted international organization is more likely to get
used. "If [the research] comes from the WHO, we know it isn't
just taken from anywhere... we have confidence in the source,"
(participant 10, male).
Authority of those who present their view
Some interviewees recognized that there is often an
uncritical reliance on specialists. Comments made by
respected individuals or those deemed extremely knowl-
edgeable in the subject area are highly influential. "We are
often not critical. As a decision-maker we should be going into
greater depth... a specialist comes in and we simply say, we're
listening... and we write it down. There is no way to contradict,
or at least construct contradictory information vis-à-vis the spe-
cialist," (participant 13, male). This could result in either a
decrease or an increase in research utilization. For exam-
ple, it was stated that a respected professor was useful as
leverage in promoting research findings to other members
of the commission. At the same time, respected individu-
als might not be basing their recommendations on
research. One policy-maker (participant 7, male) stated
that cultural factors might be at play here; as a "verbal soci-
ety" many policy-makers prefer verbal reports to docu-
mentation, and place more importance on information
that is provided to them by individuals who are highly
respected, than documents from a removed source.
Competency in research methods
Some policy-makers were involved in research studies or
programs. Having researchers act as policy-makers was
seen as a facilitator to research utilization, and not only
because they can provide research findings or act as lever-
age, but also because they are able to provide a "veritable
training in research methods" (participant 13, male). Such
training was considered important in improving other
policy-makers' competencies in research methods and
their ability to understand research presented. While most
felt that the commission members were highly qualified,
several agreed that more training in research methods
would make it easier and further motivate them to utilize
research findings. "There are always nuances in scientific
research findings... in order to adapt research findings to make
an applicable decision, and certainly when it comes to medi-
cines, I believe the commission members must have a level of
qualification sufficiently high in order to effectively exploit the
conclusions," (participant 13, male). However, one policy-
maker who participated in such a training session,
claimed to have gained little from the experience. Still
others stated that if training is to be provided, incentives
to continue working as a low-salaried civil servant must
also be included. It was also brought up that increased
competency in research methods would not only improve
policy-makers' ability to understand the research, but it
would also increase the importance they place on research
and their motivation to use it.
Priority/importance of research in making the policy
When asked about the importance of research findings in
the policy-making process, policy-makers all stated that,
while research is important, other information sources
often take precedence. Influence on the policy from
higher and lower levels in the healthcare system, such as
political will or interests and demands from patients and
healthcare professionals tend to be prioritized over
research findings.
On the other hand, several policy-makers discussed the
fact that this particular policy is highly technical and they
could not understand how one could not use research inHealth Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
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the decision-making process. "This is above all else a techni-
cal job, scientific. Its basis is science," (participant 3, male).
The extent to which policy-makers value research findings
in the policy process will influence how much it is uti-
lized.
Accountability
There was some confusion over whose role it is to look up
information. Medical professionals and specialists on the
commission felt that the technicians in the Ministry of
Health were in the best position to access and compile
research findings for consideration, while some of these
individuals felt that specialists should be supplying rele-
vant findings from their field. Having a specific person or
group of persons delegated to search and compile relevant
research findings for the policy question at hand was per-
ceived to be extremely helpful. "You cannot place the respon-
sibility on each person. If you do that it is not going to get done.
You have to have a specific group whose job it is to get the infor-
mation," (participant 13, male).
Discussion
By analyzing the selection and updating of Mali's EML,
this study discovered several factors that influence the uti-
lization of research findings by health policy-makers in a
developing country. Like most studies in this field, this
research used qualitative methods with the majority of the
data coming from in-depth interviews [6,7,14]. Qualita-
tive methods were chosen as they are "ideal for questions
that require an answer about understanding participants'
views" [12]. In using such methods, concerns about the
validity of the results can arise. It is important to recognize
that this study did not measure policy-makers' actual
behavior, nor did it measure objective factors that influ-
ence their utilization of research findings. Instead, the
findings represent policy-makers' perceptions of these fac-
tors. In addition, this study did not take into account
researchers' perceptions of these issues, as has been
explored elsewhere [15-19].
By using three separate data acquisition methods, the
validity of the findings was improved [20]. In addition to
supplementing the information from the in-depth inter-
views, the natural group discussion provided an opportu-
nity to give feedback to participants, allowing for
respondent validation [12]. The selection and number of
group members is important for effective group discus-
sions [21], but was a limitation in this study. The results
of the document analysis helped to validate participants'
statements regarding sources and documents that were
accessed. This analysis is limited however because it not
known how much consideration, if any, such documents
were allotted. The reliability of the results was improved
through the use of independent investigators in several
stages of the data analysis [22]. There are limitations in
the extent to which we can generalize the findings of this
study to other policy-makers and other developing coun-
tries, due to the exploratory nature of this study and the
fact that it examined only one aspect of policy-making in
one particular setting.
Two factors emerged from this study that are unique in the
literature: the authority of those who present their view
and the issue of accountability. These issues may be due
to the specific nature of these policy-makers or their cul-
tural setting, and so it is unclear to what extent these fac-
tors would be important in other settings. Several of the
factors emerging from this study are common in the liter-
ature, including: relevance of research findings, trust in
the research, and competency or skills of the policy-mak-
ers [3,7]. Training policy-makers in research methods and
sensitizing them to the usefulness of research findings in
the policy process has been recommended in previous
studies [18,23,24]. Training policy-makers to develop
competencies in acquiring high-quality relevant research
and adapting it for local applicability might also be bene-
ficial, since access to information was an important factor
in this study and also emerged as a barrier to research uti-
lization in a recent study involving four developing coun-
tries – two of which were African [15]. This study also
indicated that the lack of value policy-makers placed on
research findings was inhibiting its uptake. These negative
attitudes towards research have also emerged as a barrier
to research utilization in a study conducted in Mexico by
Trostle and colleagues [18]. The present study seems to
support this finding, and at the same time indicates that if
research is considered important in the policy process it
may also act as a facilitator to its utilization.
The presentation format of research findings has been
mentioned in the literature as a potential facilitator of
research utilization, for example by including summaries
with clear recommendations [18]. In developed countries,
this has been studied further, analyzing whether a specific
format such as the "1:3:25" format (1-page take-home
messages; 3-page executive summary; 25-page report)
would facilitate the utilization of research findings [3].
Policy-makers in the present study did not demonstrate a
strong preference for a specific reporting format. The gen-
eral consensus was that the report should be short, while
supplying enough information to allow them to evaluate
the quality of the research (by including the methodology
and references).
The relative importance of research findings in the policy-
process is a complex issue. For example: Mali is one of the
few countries in Africa with traditional medicines on its
EML. In discussing one of these 'improved traditional
medicines," one policy-maker mentioned having knowl-
edge of, and considering, an apparently high-quality studyHealth Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
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that had concluded that the medicine in question, while
somewhat effective, was not the most effective. For this
policy-maker, political will and community values were
more important than the difference in relative effective-
ness demonstrated by the research findings. While the
authors might not necessarily agree with the decision
made, there is potentially nothing wrong with policies
that do not directly follow research recommendations.
According to the conceptual approach to the definition of
"research utilization" from Nutley and colleagues'
adapted from Weiss, research that affects policy-makers
understanding of a situation – even if the final decision
does not follow directly from researchers' recommenda-
tions – is still being utilized [25]. Other influences such as
local values and needs are recognized as important inputs
into policy [4]. It is, after all, policy-makers who make
policy, not researchers. In this example then, even though
the research findings were considered less important, they
could still be considered as having been used in the policy
process. If several factors are working together however,
the utilization of research is likely not to occur at all. If
using research findings does not take precedence and is
already perceived as a time-consuming task in a country
where capacity to access this information is low, and no
one is quite sure who is responsible to get the informa-
tion, then chances are the research will not be read or con-
sidered, let alone influence the decisions of the policy-
maker.
Policy-makers' belief that searching, accessing and review-
ing research findings is highly time consuming is perhaps
a good argument for the increased production, promotion
and dissemination of systematic reviews. Systematic
reviews are increasingly recognized as offering many
advantages to the target audience [26], including the fact
that they lead to a more efficient use of time [3]. No pol-
icy-makers mentioned having utilized information from
systematic reviews, and most seemed unaware of their
existence. Organizations such as the Cochrane Collabora-
tion and the National Institute for Health and Clinical
Excellence of the UK are currently leading the way in pro-
viding systematic reviews for medical practice. Studies
have begun looking at how to improve their usefulness for
health care managers and policy makers [3]. Interestingly,
the Essential Medicines Department of the WHO actually
re-introduced amodiaquine in the treatment of malaria
following the publication of a systematic review from the
Cochrane Collaboration indicating its safety and effective-
ness compared with chloroquine [27]. Much work is still
needed before systematic reviews are utilized in common
practice in the formulation of policy at national levels,
especially in developing countries.
Policy-makers in the present study stated that it was
extremely helpful having trusted networks such as multi-
national organizations supply information relevant to
their decision-making. The fact that the WHO initiated
the EML policy and supplied the commission with a
model list was felt by one policy-maker to be the main rea-
son why most of the medicines on the national EML were
chosen based on evidence. These multi-national organiza-
tions can play an important role as knowledge brokers in
helping policy-makers in developing countries make
informed-decisions through continued and increased
technical support, such as the Health InterNetwork Access
to Research Initiative (HINARI) set up by the WHO [28-
30].
Perhaps the most prevalent theory discussed in the litera-
ture on this topic is the "two-communities theory" devel-
oped by Caplan and colleagues. It highlights the fact that
health researchers and policy-makers have two competing
world views [2]. Increased collaboration and personal
contact between researchers and policy-makers have been
proposed and studied as solutions to the problems related
this issue [31]. While these concepts were discussed in the
interviews, the authors agreed that they did not emerge as
factors  per se. They were seen as indirect influences.
Increased collaboration and personal contact between
researchers and policy-makers could lead to increased
access to information, improve policy-makers' trust in the
research, enhance their understanding of, and compe-
tency in, research methods and the skills required to
access research findings, and allow them to influence the
research and make it more relevant to their own needs.
This last point, while seemingly good for policy-makers,
can pose potential problems to the objectivity and quality
of research produced [7,32].
With the limited number of studies from developing
countries on this topic, further research seems necessary.
The factors emerging from this study, including those that
are not common in the literature, warrant further investi-
gation and should be considered in the planning of strat-
egies to bridge the gap between research findings and
policy-making. How best to advocate the critical evalua-
tion of all information sources, and the delegation of the
specific task to search for research findings, as suggested
by the policy-makers, remains unresolved. Different
approaches to analyzing these issues will be important for
future research. The present study analyzed the utilization
of research at one stage in the policy-making process – the
selection of specific medicines for an EML. The types of
factors influencing the utilization of research findings
likely differs in other levels of policy-making – for exam-
ple the decision to have an EML in the first place. Getting
an overall analysis of all levels of policy-formulation will
be important for future research. Finally, it will be impor-
tant to continue examining the effectiveness of strategies
used to improve the uptake of research findings, such asHealth Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
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case studies of collaborative research projects between
researchers and policy-makers and analyses of the use of
knowledge brokers in bridging these two communities.
Conclusion
In order to determine the factors influencing policy mak-
ers' utilization of research findings in a developing coun-
try, this qualitative study examined health policy-makers'
experiences in the selection and updating of Mali's EML.
Due to the nature of the methods used, there are limita-
tions to how far these factors can be generalized to other
settings or other health policies. That said, many of the
factors that emerged in this research have been found in
similar studies in the literature. These factors support the
issues related to the "two-communities theory" common
in the literature, and highlight the importance of bridging
these communities in order to improve the uptake of
research findings.
Improving the transfer of research to policy will require
effort on the part of policy-makers, the research commu-
nity, and third parties. Policy-makers are likely to increase
their utilization of research findings if their competency in
research methods is improved and the importance they
place on research findings in the policy-making process is
increased. Providing these policy-makers with informa-
tion they feel they can trust is also essential. Researchers
can also improve the uptake of their research by making
efforts to investigate policy-relevant issues. Increased col-
laboration between researchers and policy-makers and
continued and improved technical support from various
networks and multi-national organizations will put pol-
icy-makers in a better position to make more informed
decisions so that the best health policies may be imple-
mented in settings where the population potentially has
the most to gain.
Competing interests
DM works for the Direction of Pharmaceuticals and Med-
icines within the Ministry of Health in Mali and will be
taking part in the next updating of the Malian EML.
Authors' contributions
MA conceived of the study, participated in its design, col-
lected the data, performed the analysis, and wrote the ini-
tial draft of the manuscript. AF participated in the
conception and design of the study, offered technical sup-
port to the principle investigator during implementation,
contributed to the analysis and helped prepare the draft
manuscript. DM contributed to the acquisition of data,
and made critical comments on the draft manuscript. All
authors read and approved the final manuscript.
Additional material
Acknowledgements
This project was the basis for MA's Masters Thesis in International Com-
munity Health at the University of Oslo (UiO). MA received support to 
complete this study from the Nordic Africa Institute and Helle's Legat. The 
views expressed herein are those of the authors, and may not represent the 
views of the funders. The authors would like to thank the following people: 
the policy-makers in Mali who volunteered their time to participate in this 
study, Simon Lewin for his comments on the protocol and interview guide, 
Kirsten Myhr for her technical support on EMLs, Jan Frich and John Lavis 
for their comments on the original manuscript, and Dr. Drissa Diallo and 
Berit Paulsen for their local support in Mali.
References
1. Weiss CH: Using social research in public policy making.  Lex-
ington, Mass.: Lexington Books; 1977. 
2. Caplan N, Morrison A, Stambaugh RJ: The use of social science
knowledge in policy decisions at the national level: a report
to respondents.  Ann Arbor: Institute for Social Research, Univer-
sity of Michigan; 1975. 
3. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E:
Towards systematic reviews that inform health care man-
agement and policy-making.  J Health Serv Res Policy 2005,
10(Suppl 1):35-48.
4. Walt G: Health Policy: An Introduction to Process and
Power.  London, Zed Books; 1994. 
5. Weiss C: The many meanings of research utilization.  Public
Adm Rev 1979, 39:426-431.
6. Hanney SR, Gonzalez-Block MA, Buxton MJ, Kogan M: The utilisa-
tion of health research in policy-making: concepts, examples
and methods of assessment.  Health Res Policy Syst 2003, 1:2.
7. Innvaer S, Vist G, Trommald M, Oxman A: Health policy-makers'
perceptions of their use of evidence: a systematic review.  J
Health Serv Res Policy 2002, 7:239-244.
8. Garner P, Kale R, Dickson R, Dans T, Salinas R: Getting research
findings into practice: implementing research findings in
developing countries.  BMJ 1998, 317:531-535.
9. WHO: WHO Model List (revised March 2005).  Essential Medi-
cines. Geneva 2005.
10. Quick JD, Management Sciences for Health, World Health Organiza-
tion, Action programme on essential drugs: Managing drug supply:
the selection, procurement, distribution, and use of pharma-
ceuticals.  2nd edition. West Hartford, Conn.: Kumarian Press;
1997. 
11. Orientations de la politique pharmaceutique nationale
[http://www.dirpharma.org]
12. Green J, Thorogood N: Qualitative methods for health
research.  London: Sage; 2004. 
13. Giorgi A: Sketch of a psychological phenomenological
method.  In Phenomenology and psychological research: essays Edited
by: Giorgi A. Pittsburgh, Pa.: Duquesne University Press; 1985:8-22. 
14. Lavis J, Ross S, McLeod C, Gildiner A: Measuring the impact of
health research.  J Health Serv Res Policy 2003, 8(3):165-170.
15. Hennink M, Stephenson R: Using research to inform health pol-
icy: barriers and strategies in developing countries.  J Health
Commun 2005, 10(2):163-180.
16. Aaserud M, Lewin S, Innvaer S, Paulsen E, Dahlgren A, Trommald M,
Duley L, Zwarenstein M, Oxman A: Translating research into
policy and practice in developing countries: a case study of
Additional File 1
Interview guide. In-depth, semi-structured interview guide used in the 
study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1478-
4505-5-2-S1.doc]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health Research Policy and Systems 2007, 5:2 http://www.health-policy-systems.com/content/5/1/2
Page 8 of 8
(page number not for citation purposes)
magnesium sulphate for pre-eclampsia.  BMC Health Services
Research 2005, 5(1):68.
17. Moodley J, Jacobs M: Research to action and policy: combating
Vitamin A deficiencies in South Africa.  In Lessons in Research to
Action and Policy – Case studies from seven countries Geneva: The Coun-
cil of Health Research and Development (COHRED) Working Group
on Research to Action and Policy; 2000:54-66. 
18. Trostle J, Bronfman M, Langer A: How do researchers influence
decision-makers? Case studies of Mexican policies.  Health Pol-
icy Plan 1999, 14:103-114.
19. Gerhardus A, Kielmann K, Sanou A: The use of research for deci-
sion-making in the health sector: the case of "shared care" in
Burkina Faso.  In Lessons in Research to Action and Policy – Case studies
from seven countries Geneva: The Council of Health Research and
Development (COHRED) Working Group on Research to Action
and Policy; 2000:19-27. 
20. Denzin NK: The research act; a theoretical introduction to
sociological methods.  Chicago: Aldine Pub Co; 1970. 
21. Knodel J: The design and analysis of focus group studies. A
practical approach.  In Successful focus groups: advancing the state of
the art Edited by: Morgan DL. Newbury Park, Calif.: Sage; 1993:35-50. 
22. Silverman D: Interpreting qualitative data: methods for ana-
lysing talk, text and interaction.  2nd edition. London: Sage; 2001. 
23. Chunharas S: Research to action and policy: the need for a new
concept.  In Lessons in Research to Action and Policy – Case studies from
seven countries Geneva: The Council on Health Research for Develop-
ment (COHRED) Working Group on Research to Action and Policy;
2000:1-8. 
24. Sauerborn R, Nitayarumphong S, Gerhardus A: Strategies to
enhance the use of health systems research for health sector
reform.  Trop Med Int Health 1999, 4:827-835.
25. Nutley S, Walter I, Davies HTO: From Knowing to Doing: A
Framework for Understanding the Evidence-into-Practice
Agenda.  Evaluation 2003, 9(2):125-148.
26. Mulrow CD: Rationale for systematic reviews.  In Systematic
Reviews Edited by: Chalmers I, Altman DG. London: BMJ Publishing
Group; 1995:1-8. 
27. Volmink J, Siegfried N, Robertson K, Gulmezoglu AM: Research
synthesis and dissemination as a bridge to knowledge man-
agement: the Cochrane Collaboration.  Bull World Health Organ
2004, 82(10):778-783.
28. Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J, Knowl-
edge Transfer Study G: How can research organizations more
effectively transfer research knowledge to decision makers?
Milbank Q 2003, 81:221-248.
29. Bridging the "Know-Do" Gap, Meeting on Knowledge Trans-
lation in Global Health.  Geneva: World Health Organization;
2006. 
30. Health InterNetwork Access to Research Initiative   [http://
www.who.int/hinari/en/]
31. Ross S, Lavis J, Rodriguez C, Woodside J, Denis JL: Partnership
experiences: involving decision-makers in the research proc-
ess.  J Health Serv Res Policy 2003, 8(Suppl 2):26-34.
32. Polanyi M: The Republic of Science – its political and economic
theory.  Minerva 1962, 1:54-73.